Adar Poonawalla, Serum Institute of India CEO (Dhiraj Singh/Bloomberg via Getty Images)
Serum Institute subsidiary invests another $150M into Biocon
Biosimilar manufacturer Biocon said Tuesday that the Serum Institute of India is making another $150 million investment, doubling a prior investment from last November. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.